Related Articles
NATURAL-KILLER CELL-MEDIATED CYTOTOXICITY OF BLOOD-LYMPHOCYTES FROM PATIENTS WITH MALIGNANT MESOTHELIOMA TREATED BY INTRAPLEURAL INTERLEUKIN-2
Recombinant interleukin-2 stimulates lymphocyte recovery in patients with severe COVID-19
LACK OF CORRELATION BETWEEN DEFECTIVE CELL-MEDIATED-IMMUNITY AND LEVELS OF SECRETED OR CIRCULATING CYTOKINES IN A STUDY OF 90 CANCER-PATIENTS
EVALUATION OF PHAGOCYTIC-ACTIVITY IN NEOPLASTIC PATIENTS TREATED WITH SUBCUTANEOUS RECOMBINANT IL-2
Analysis of the proliferative and phenotypic properties of tumor infiltrating lymphocytes expanded in vitro in the course of the clinical trial of adoptive immunotherapy of metastatic melanoma